Abiopharma

🔍 Williams Gregg (Director)

Company: Vivani Medical, Inc. (VANI)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 1,587,301 shares of Common Stock at $1.26 per share (Direct)
  Date: 2026-04-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 32,944,484.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: H | shares_owned_after: 4,799,200.00

Footnotes:

• F1: The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
• F2: The reporting person owns 37,743,684 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 30,818,732 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.